November 20, 2023, Mind Medicine Inc (NASDAQ: MNMD) trading session started at the price of $2.57, that was 6.18% jump from the session before. During the day, the shares moved up to $2.765 and dropped to $2.54 before settling in for the closing price of $2.59. A 52-week range for MNMD has been $2.12 – $5.01.
When this article was written, the company’s average yearly earnings per share was at -21.83%. With a float of $26.44 million, this company’s outstanding shares have now reached $37.98 million.
Considering the fact that the conglomerate employs 48 people, you should pay attention to its efficiency factor.
Mind Medicine Inc (MNMD) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Mind Medicine Inc stocks. The insider ownership of Mind Medicine Inc is 6.11%, while institutional ownership is 13.31%. The most recent insider transaction that took place on Sep 25, was worth 48,274. In this transaction Chief Executive Officer of this company sold 13,499 shares at a rate of $3.58, taking the stock ownership to the 611,729 shares. Before that another transaction happened on Sep 25, when Company’s Chief Medical Officer sold 6,918 for $3.57, making the entire transaction worth $24,730. This insider now owns 371,804 shares in total.
Mind Medicine Inc (MNMD) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/29/2023, it has been observed that the corporation posted -$0.45 earnings per share (EPS) during the time that was better than consensus figure (set at -$0.67) by $0.22. This company achieved a return on equity of -37.54. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -21.83% per share during the next fiscal year.
Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators
You can see what Mind Medicine Inc (MNMD) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.99, a number that is poised to hit -0.44 in the next quarter and is forecasted to reach -1.91 in one year’s time.
Technical Analysis of Mind Medicine Inc (MNMD)
Compared to the last year’s volume of 0.48 million, its volume of 0.38 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 39.15%. Additionally, its Average True Range was 0.18.
During the past 100 days, Mind Medicine Inc’s (MNMD) raw stochastic average was set at 13.08%, which indicates a significant decrease from 46.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 95.62% in the past 14 days, which was higher than the 72.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.04, while its 200-day Moving Average is $3.52. Nevertheless, the first resistance level for the watch stands at $2.83 in the near term. At $2.91, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.06. If the price goes on to break the first support level at $2.61, it is likely to go to the next support level at $2.46. Now, if the price goes above the second support level, the third support stands at $2.38.
Mind Medicine Inc (NASDAQ: MNMD) Key Stats
There are 39,717K outstanding shares of the company, which has a market capitalization of 77.44 million. As of now, sales total 0 K while income totals -56,800 K. Its latest quarter income was 0 K while its last quarter net income were -17,920 K.